Updated
Updated · The Boston Globe · Jun 11
Kennedy Jr. Withholds $600 Million for Gavi as Congress Faces Calls to Force Release
Updated
Updated · The Boston Globe · Jun 11

Kennedy Jr. Withholds $600 Million for Gavi as Congress Faces Calls to Force Release

1 articles · Updated · The Boston Globe · Jun 11

Summary

  • $600 million in congressionally appropriated funds for Gavi is being held back by HHS Secretary Robert F. Kennedy Jr., prompting calls for Congress to pressure the Trump administration to release the money.
  • The appeal argues that vaccine funding is the most effective defense against cross-border outbreaks including Ebola, AIDS, tuberculosis and malaria, especially after the administration withdrew from USAID and the World Health Organization.
  • Marco Rubio has said he is prepared to take over the Gavi vaccine program from Kennedy, adding an internal administration option for restoring the funding flow.
  • Gavi says it has vaccinated nearly 1.2 billion children in low-income countries since 2000, making the funding dispute significant for global immunization efforts.

Insights

With US funds frozen, how many preventable child deaths could occur globally before the September deadline?
As the US vacates its Gavi board seat, which nations might step in to fill the leadership void?
When government policy clashes with scientific consensus on vaccines, what are the worldwide consequences?

U.S. $600 Million Gavi Funding Standoff: Vaccine Safety Dispute Threatens Global Immunization and American Leadership

Overview

In June 2026, U.S. Secretary of State Marco Rubio announced that the State Department would take a renewed, leading role in deciding the future of U.S. funding for Gavi, the Vaccine Alliance. This marks a shift from the president’s earlier decision to have Health Secretary Robert F. Kennedy Jr., known for his strong views on vaccine safety, lead the process. The State Department’s re-engagement aims to resolve a critical impasse over vaccine safety claims and scientific consensus, with a looming September deadline for releasing $600 million in approved funds. The outcome will have major consequences for global vaccination efforts and U.S. global health leadership.

...